Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias

International Psychogeriatrics

Volumn 10, Issue 3, 1998, Pages 271-302

  Jobst, Kim A ^a,b,c   Barnetson, Lin P D ^a,b   Shepstone, Basil J ^a,b  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARIETAL LOBE; PREDICTION; PROSPECTIVE STUDY; REGIONAL PERFUSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; X RAY SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BIOPSY; CASE-CONTROL STUDIES; DECISION TREES; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031658438     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610298005389     Document Type: Article

References (84)

1. Alavi, A. M., Reivich, S., Ferris, D., Christman, J., Fowler, R., et al. (1982). Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. Experimental Brain Research, 5(Suppl.), 187-195.
2. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
3. Ball, M. J., Hachinski, V., Fox, A., Kirshen, A. J., Fisman, M., et al. (1985). A new definition of Alzheimer's disease: A hippocampal dementia. The Lancet, 1, 14-16.
4. Berg, L., & Morris, J. C. (1994). Diagnosis. In R. D. Terry, R. Katzman, & K. L. Bick (Eds.), Alzheimer disease (pp. 9-25). New York: Raven Press.
5. Bonte, F. J., Tintner, R., Weiner, M. F., Bigio, E. H., & White, C. L. III. (1993). Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology, 186, 361-365.
6. Braak, H., & Braak, E. (1991a). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82, 239-259.
7. Braak, H., & Braak, E. (1991b). Neurofibrillary changes confined to the entorhinal region in cases of presenile dementia. In T. Ishii (Ed.), Frontiers of Alzheimer research (pp. 123-130). New York: Elsevier Science.
8. Brayne, C. (1994). How common are cognitive impairment and dementia? An epidemiological viewpoint. In F. A. Huppert, C. Brayne, & D. W. O'Connor (Eds.), Dementia and normal aging (pp. 167-208). Cambridge, UK: Cambridge University Press.
9. Brun, A., Gustafson, L., & Ingvar, D. (1975). Neuropathological findings related to neuropsychiatric symptoms and cerebral blood flow in presenile dementia: Seventh International Congress of Neuropathology, Budapest (pp. 101-105). Amsterdam: Excerpta Medica.
10. Burns, A. (1993). Brain imaging: Computed tomography in Alzheimer's disease. Lancet, 341, 601-602.
11. Clarfield, A. M. (1988). The reversible dementias: Do they reverse? Annals of Internal Medicine, 109, 476-486.
12. Convit, A., de Leon, M. J., De Santi, S., Kluger, A., Rusinek, H., et al. (1995). Hippocampal volume losses in minimally impaired elderly. Lancet, 345, 266.
13. Cutler, N. R., Duara, R., Creasey, H., Grady, C. L., Haxby, J. V., et al. (1984). Brain imaging: aging and dementia (NIH Conference). Annals of Internal Medicine, 101, 355-369.
14. De Leon, M. J., Ferris, S. H., George, A. E., Christman, D. R., Fowler, J. S., et al. (1983). Positron emission tomographic studies of aging and Alzheimer disease. American Journal of Neuroradiology, 4, 568-571.
15. De Leon, M. J., Golomb, J., George, A. E., Convit, A., Tarshish, C. Y., et al. (1993). The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation. American Journal of Neuroradiology, 14, 897-906.
16. DeCarli, C., Grady, C. L., Clark, C. M., Kayz, D. A., Brady, D. R., et al. (1996). Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. Journal of Neurology, Neurosurgery and Psychiatry, 60, 158-167.
17. DeCarli, C., Kaye, J. A., Horwitz, B., & Rapoport, S. I. (1990). Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology, 40, 872-883.
18. DeCarli, C., Murphy, D. G. M., Tranh, M., Grady, C. L., Haxby, J. V., et al. (1995). The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology, 45, 2077-2084.
19. Delacoste, M. C., & White, C. L. (1993). The role of cortical connectivity in Alzheimer's disease pathogenesis - a review and model system. Neurobiology of Aging, 14, 1-16.
20. de Leon, M. J., Convit, A., De Santi, S., Tarshish, C., & Rusinek, H. (1996, November 17-19). Hippocampal atrophy predicts future AD and lateral temporal lobe atrophy is associated with dementia. Paper presented at the International Consensus Meeting on Diagnosis in Dementia, Geneva, Switzerland.
21. Devous, M. D., Thisted, R. A., Jagust, W. J., George, M. S., Van Heertum, R. L., et al. (1995). Meta analysis of SPECT brain imaging in dementia. Journal of Nuclear Medicine, 36, 107P.
22. Drayer, B. P. (1988). Imaging of the aging brain: 2. Pathologic conditions. Radiology, 166, 797-806.
23. Eberling, J. L., Jagust, W. J., Reed, B. R., Kwoon-Yuen, P. F., & Martin, E. M. (1992). Single photon emission computed tomography studies of regional cerebral blood flow in multiple infarct dementia. Journal of Neuroimaging, 2, 79-85.
24. Eberling, J. L., Reed, B. R., Baker, M. G., & Jagust, W. J. (1993). Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. Archives of Neurology, 50, 761-766.
25. Englund, E., Brun, A., & Persson, B. (1987). Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer's Disease and Associated Disorders, 1, 156-170.
26. Esiri, M. M., Pearson, R. C. A., Steele, J. E., Bowen, D. M., & Powell, T. P. S. (1990). A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 53, 161-165.
27. Fox, N. C., Freeborough, P. A., & Rossor, M. N. (1996a). Visualization and quantification of rates of atrophy in Alzheimer's disease. Lancet, 348, 94-97.
28. Fox, N. C., Warrington, E. K., Stevens, J. M., & Rossor, M. N. (1996b). Atrophy of the hippocampal formation in early familial Alzheimer's disease: A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717 val-gly mutation. In J. H. Growdon, R. M. Nitsch, S. Corkin, & R. J. Wurtman (Eds.), The neurobiology of Alzheimer's disease. New York: Annals of the New York Academy of Sciences, 777, 226-232.
29. Frackowiak, R. S. J., & Friston, K. J. (1994). Functional neuroanatomy of the human brain: Positron emission tomography - a new neuroanatomical technique. Journal of Anatomy, 184, 211-225.
30. George, A. E., De Leon, M. J., Gentes, C. I., Miller, J., London, E., et al. (1986). Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies. American Journal of Neuroradiology, 7, 561-566.
31. Goldman-Rakic, P. S. (1987). Circuitry of the frontal association cortex and its relevance to dementia. Archives of Gerontology and Geriatrics, 6, 299-309.
32. Goldman-Rakic, P. S., Selemon, L. D., & Schwartz, M. L. (1984). Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience, 12, 719-743.
33. Grady, C. L., Haxby, J. V., Horwitz, B., Berg, G., & Rapoport, S. I. (1987). Neuropsychological and cerebral metabolic function in early vs. late onset dementia of the Alzheimer type. Neuropsychologia, 25, 807-816.
34. Greene, J. D. W., Miles, K., & Hodges, J. R. (1996). Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of the Alzheimer type. Journal of Neurology, 243, 175-190.
35. Gustafson, L., Brun, A., & Ingvar, D. H. (1977). Presenile dementia: Clinical symptoms, pathoanatomical findings and cerebral blood flow. In J. S. Meyer, H. Lechner, & M. Reivich (Eds.), Cerebral vascular disease (Vol. 425, pp. 5-9). Amsterdam: Excerpta Medica.
36. Gustafson, L., & Risberg, J. (1979). Regional cerebral blood flow measurements by the 133-Xe inhalation technique in differential diagnosis of dementia. Acta Neurologica Scandinavica, 60 (Suppl. 72), 546-547.
37. Gustafson, L., Risberg, J., Johanson, M., & Brun, A. (1984). Evaluation of organic dementia by regional cerebral blood flow measurements and clinical and psychometric methods. Monographs in the Neural Sciences, 11, 111-117.
38. Haxby, J. V., Duara, R., Grady, C. L., Cutler, N. R., & Rapoport, S. I. (1985). Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism, 5, 193-200.
39. Holman, B. L., & Devous, M. D. (1992). Functional brain SPECT: The emergence of a powerful clinical method. Journal of Nuclear Medicine, 33, 1888-1904.
40. Holman, B. L., Hunink, M. G. M., Johnson, K. A., Garada, B., & Satlin, A. (1992a). Patterns of dementia in Alzheimer's disease - reply [Letter]. Journal of Nuclear Medicine, 33, 1432.
41. Holman, B. L., Johnson, K. A., Gerada, B., Carvalho, P. A., & Satlin, A. (1992b). The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. Journal of Nuclear Medicine, 33, 181-185.
42. Huppert, F. A., Brayne, C., & O'Connor, D. W. (Eds.). (1994). Dementia and normal aging. New York: Cambridge University Press.
43. Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984). Alzheimer's disease: Cell specific pathology isolates the hippocampal formation. Science, 225, 1168-1170.
44. Ingvar, D., Brun, A., & Gustafson, L. (1978). Regional cerebral blood flow in the dominant hemisphere in confirmed cases of Alzheimer's disease, Pick's disease, and multi-infarct dementia: The relationship to clinical symptomatology and neuropathological findings. In R. Katzman, R. D. Terry, & K. L. Bick (Eds.), Alzheimer's disease: Senile dementia and related disorders (pp. 203-211). New York: Raven Press.
45. Jagust, W. A., Johnson, K. A., & Holman, B. L. (1995). SPECT perfusion imaging in the diagnosis of dementia. Journal of Neuroimaging, 5(Suppl.), S45-S52.
46. Jagust, W. J., & Eberling, J. L. (1991). MRI, CT, SPECT, PET: Their use in diagnosing dementia. Geriatrics, 46, 28-35.
47. Jagust, W. J., Reed, B. R., Ellis, W. G., Eberling, J. L., & Budinger, T. F. (1993). Single photon emission computed tomographic perfusion imaging in autopsy-diagnosed dementia. Journal of Neuroimaging, 3, 93-99.
48. Jobst, K. A. (1996). Neuroimaging in Alzheimer's disease: A prospective, longitudinal, clinico-pathological study. Doctor of Medicine Thesis, Bodleian Library, Oxford University, Oxford, UK.
49. Jobst, K. A., Hindley, N. J., King, E., & Smith, A. D. (1994a). The diagnosis of Alzheimer's disease: A question of image? Journal of Clinical Psychiatry, 55, 22-31.
50. Jobst, K. A., Smith, A. D., Barker, C. S., Wear, A., King, A. M., et al. (1992a). Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 55, 190-194.
51. Jobst, K. A., Smith, A. D., Szatmari, M., Esiri, M. M., Jaskowski, A., et al. (1994b). Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet, 343, 829-830.
52. Jobst, K. A., Smith, A. D., Szatmari, M., Molyneux, A., Esiri, M. M., et al. (1992b). Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet, 340, 1179-1183.
53. Johnson, K. A., Mueller, S. T., Walshe, T. M., English, R. J., & Holman, B. L. (1987). Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Archives of Neurology, 44, 165-168.
54. Kennedy, A. M., Frackowiak, R. S. J., Newman, S. K., Bloomfield, P. M., Seaward, J., et al. (1995). Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neuroscience Letters, 186, 17-20.
55. King, E., Smith, A., & Jobst, K. A. (1993). Autopsy: Consent, completion and cooperation in Alzheimer's disease research. Age and Ageing, 22, 209-214.
56. Kukull, W. A., Larson, E. B., Reifler, B. V., Lampe, T. H., Yerby, M. S., et al. (1990a). The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology, 40, 1364-1369.
57. Kukull, W. A., Larson, E. B., Reifler, B. V., Lampe, T. H., Yerby, M., et al. (1990b). Inter-rater reliability of Alzheimer's disease diagnosis. Neurology, 40, 257-260.
58. Leys, D., Pruvo, J. P., Parent, M., Vermersch, P., Soetaert, G., et al. (1991). Could Wallerian degeneration contribute to "leukoaraiosis" in subjects free of any vascular disorder? Journal of Neurology, Neurosurgery and Psychiatry, 54, 46-50.
59. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., et al. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
60. Meyer, J. S., Shirai, T., & Akiyama, H. (1996). Neuroimaging for differentiating vascular from Alzheimer's disease. Cerebrovascular and Brain Metabolism Reviews, 8, 1-10.
61. Mielke, R., Schroder, R., Fink, G. R., Kessler, J., Herholz, K., & Heiss, W.-D. (1996). Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathologica, 91, 174-179.
62. Mirra, S. S., Hart, M. N., & Terry, R. D. (1993). Making the diagnosis of Alzheimer's disease: A primer for practicing pathologists. Archives of Pathology & Laboratory Medicine, 117, 132-144.
63. Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., et al. (1991). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): 2. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479-486.
64. Molyneux, A. J., Jobst, K. A., Hindley, N. J., & Smith, A. D. (1995). Radiological detection of proven Alzheimer's disease during life using CT evidence of minimum medial temporal lobe thickness. Journal of Neuroradiology, 37(Suppl.), 197-199.
65. Morrison, J. H. (1993). Differential vulnerability, connectivity, and cell typology. Neurobiology of Aging, 14, 51-54.
66. Nagy, Z., Esiri, M. M., Jobst, K. A., Johnston, C., Litchfield, S., et al. (1995a). Influence of the ApoE genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience, 69, 757-761.
67. Nagy, Z., Esiri, M. M., Jobst, K. A., Morris, J. H., King, E. M.-F., et al. (1995b). Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria. Dementia, 6, 21-31.
68. Nagy, Z. S., Esiri, M. M., Joachim, C., Jobst, K. A., Morris, J. H., et al. (in press). Comparison of pathological diagnostic criteria for Alzheimer's disease. Alzheimer's Disease and Associated Disorders.
69. Philpot, M. P., Costa, D. C., Burns, A., Levy, R., & Ell, P. J. (1991). Single photon emission tomography in Alzheimer's disease. A longitudinal study of changes in relative regional cerebral blood flow. International Journal of Geriatric Psychiatry, 6, 767-774.
70. Philpot, M., & Burns, A. (1993). Jobst et al's "Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography." British Journal of Psychiatry, 163, 809-812.
71. Rapoport, S. I., Horwitz, B., Haxby, J. V., & Grady, C. L. (1986). Alzheimer's disease: Metabolic uncoupling of associative brain regions. Cancer Journal of Neurological Sciences, 13(Suppl.), 540-545.
72. Roses, A. D. (1995). Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Annals of Neurology, 38, 6-14.
73. Rossor, M. N., Newman, S., Frackowiak, R. S., Lantos, P., & Kennedy, A. M. (1993). Alzheimer's disease families with amyloid precursor protein mutations. Annals of the New York Academy of Sciences, 695, 198-202.
74. Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., et al. (1986). CAMDEX: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698-709.
75. Roy, C. S., & Sherrington, C. S. (1980). On the regulation of the blood-supply of the brain. Journal of Physiology, 2, 85-108.
76. Saunders, A. M., Hulette, C., Welsh-Bohmer, K. A., Schmechel, D. E., Crain, B., et al. (1996). Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet, 348, 90-93.
77. Small, G. W., la Rue, A., Komo, S., Kaplan, A., & Mandelkern, M. A. (1995). Predictors of cognitive change in middle-aged and older adults with memory loss. American Journal of Psychiatry, 152, 1757-1764.
78. Smith, A. D., & Jobst, K. A. (1996). Use of structural imaging to study the progression of Alzheimer's disease. British Medical Bulletin, 52, 575-586.
79. Smith, A. D., Jobst, K. A., Edmonds, Z., Hindley, N. J., & King, E. M.-F. (1996a). Neuroimaging and early Alzheimer's disease. Lancet, 348, 829-830.
80. Smith, A. D. Jobst, K. A., Johnston, C., Joachim, C., & Nagy, Z. (1996b). Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet, 348, 483-484.
81. Sokoloff, L. (1977). Relation between physiological function and metabolism in the central nervous system. Journal of Neurochemistry, 29, 13-26.
82. Van Gool, W. A., Walstra, G. J. M., Teunisse, S., Van der Zant, F. M., Weinstein, H. C., et al. (1995). Diagnosing Alzheimer's disease in elderly, mildly demented patients: The impact of routine single photon emission computed tomography. European Neurology, 242, 401-405.
83. Waldemar, G. (1995). Functional brain imaging with SPECT in normal aging and dementia. Cerebrovascular and Brain Metabolism Reviews, 7, 89-130.
84. Waldemar, G., Bruhn, P., Kristensen, M., Johnsen, A., Paulson, O. B., et al. (1994). Heterogeneity of neocortical cerebralblood flow deficits in dementia of the Alzheimer type: A [99mTc]-d, 1-HMPAO SPECT study. Journal of Neurology, Neurosurgery and Psychiatry, 57, 285-295.